Why Is PRAXIS PRECISION MED (PRAX) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 17, 2026 at 1:18 PM ET · reviewed against 1 wire stories
PRAXIS PRECISION MED (PRAX) is drawing unusual attention today. Our newswire has captured 1 story on PRAX across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why PRAX stock is up today
PRAX stock surged 6.37% to $390.19 in a single session driven by a price target increase from Raymond James. The stock opened at $367.50 and climbed to a high of $391.64 before settling near the high at $390.00. The move reflects growing optimism around the company's pipeline outlook.
What Happened
Raymond James raised its price target for Praxis Precision Medicines from $765 to $945. This action was cited as a key factor in the stock's performance. Additional upgrades from RBC Capital, Wells Fargo, and Needham also contributed to the positive momentum. RBC Capital raised its price target to $462, while Wells Fargo set its target at $362 and Needham at $582. These analyst actions underscored a broader trend of increased confidence in the company's prospects.
What The Data Shows
The stock has shown strong performance over the past eight sessions, rising 14.2% from $319.23 to $364.44. The current session saw volume of 0.2 million shares, which is 0.4 times the 3-month daily average. The stock is trading near its 52-week high of $388.00 and has printed 23 fresh 52-week highs on August 17, 2026. Despite a market cap of $10.1 billion, the company remains unprofitable with an EPS of -12.86 for the trailing twelve months. Revenue, however, has grown by 365.0% over the same period.
What To Watch
The stock is set to continue under the microscope as coverage breadth expands. Investors may also watch for future earnings releases and further analyst commentary on the company's pipeline developments.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
H.C. Wainwright reiterates Praxis Precision stock rating on pipeline potential
H.C. Wainwright reiterates Praxis Precision stock rating on pipeline potential
Frequently asked questions
Why is PRAX stock moving today?
PRAXIS PRECISION MED (PRAX) is drawing unusual attention today. Our newswire has captured 1 story on PRAX across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 56/100). The most recent driver: "H.C. Wainwright reiterates Praxis Precision stock rating on pipeline potential" (Investing.com Analyst Ratings).
Is PRAX a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of PRAX coverage reads 56/100 over 1 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →